Wegovy Helped Children With Obesity in a New Trial

a person injecting the patient

Introduction

Novo Nordisk shared new results for Wegovy on November 16, 2026. The results come from a trial in children aged 6 to under 12 who live with obesity. Obesity means a person has a lot of extra body fat, and it can hurt their health. The trial tested if Wegovy could help these children in a safe way. The drug is not yet approved for this age group.

What Happened

The trial is called STEP Young, and it included 167 children. About 112 children got Wegovy, and 55 children got a placebo. A placebo is a treatment with no real drug in it, and it helps doctors compare results. All the children also got help with food and movement, like a lower-calorie diet and more physical activity. The main test lasted 68 weeks, which is a little more than one year.

  • Children in the trial: 167
  • Ages: 6 to under 12
  • BMI change with Wegovy after 68 weeks: down 17.4%
  • BMI change with placebo after 68 weeks: up 2.2%
  • Children on Wegovy who no longer had obesity: more than 40%

BMI is a number that compares weight and height, and doctors use it to check if a person has obesity. In the trial, the Wegovy group had a BMI fall of 17.4%, while the placebo group had a BMI rise of 2.2%. That is a difference of 19.7 percentage points. Nearly 79% of the children on Wegovy had a BMI fall of at least 10%, while no child on placebo did.

Why It Happened

Wegovy works by copying a natural signal in the body that controls hunger. The signal is called GLP-1, and it can help a person feel full sooner and eat less. Novo Nordisk makes Wegovy as a weekly injection. An injection is a shot that puts the drug into the body.

At the start, 85% of the children had moderate to severe obesity. Nearly half of them already had at least one health problem linked to obesity, like high blood pressure, high cholesterol, or sleep apnea. The children were watched for safety, growth, and puberty.

Why It Matters

Childhood obesity is a big health problem around the world. In 2025, about 177 million children and teens aged 5 to 19 lived with obesity, according to the World Obesity Federation. The group says that number could reach 228 million by 2040. Wegovy is already approved for children aged 12 and older, but no drug is approved for children under 12.

This news also matters for the business of Novo Nordisk, because Wegovy is one of its most important drugs. A wider use could mean more patients, but approval is not certain yet. For a simple look at another weight-loss drug story, read our post about Eli Lilly’s obesity pill and sleep apnea.

What Happens Next

Next, health officials will look at the full results and decide if Wegovy can be used for children under 12. The results were published in The New England Journal of Medicine, and they were shared at ObesityWeek 2026. The two-year study does not show what happens over many years, so doctors will keep watching the long-term results.

Final Thoughts

The trial gives a clear and simple message. Wegovy helped many young children lower their BMI in this study, and the safety results were in line with what doctors see in adults. Most side effects were mild stomach problems. Still, this is only one study, and approval for younger children is not certain yet.

Quick Questions

What did the Wegovy trial find in children? In children aged 6 to under 12, Wegovy cut BMI by 17.4% after 68 weeks, while the placebo group rose by 2.2%.

Is Wegovy approved for children under 12? No, it is not approved for children under 12 yet. It is already approved for children aged 12 and older.

How many children were in the trial? The trial included 167 children. About 112 children got Wegovy, and 55 children got a placebo.

Disclaimer: This article is for educational and informational purposes only and does not constitute financial advice.

Sources: CNBC and Novo Nordisk / PR Newswire. Photo: Pexels free photo of a person receiving an injection.

Comments

2 responses to “Wegovy Helped Children With Obesity in a New Trial”

  1. […] for the public health response alone. For another health story from this week, read our post about Wegovy and children. Health news can also change how companies and markets think about […]

  2. […] is a new pill for weight loss. It is called Wegovy. You swallow it once a day. There is no needle. New numbers show it works well in real life. People […]

Leave a Reply